Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR Studies.
Chayrov R, Parisis NA, Chatziathanasiadou MV, Vrontaki E, Moschovou K, Melagraki G, Sbirkova-Dimitrova H, Shivachev B, Schmidtke M, Mitrev Y, Sticha M, Mavromoustakos T, Tzakos AG, Stankova I. Chayrov R, et al. Among authors: melagraki g. Molecules. 2020 Sep 1;25(17):3989. doi: 10.3390/molecules25173989. Molecules. 2020. PMID: 32883012 Free PMC article.
An ancestral molecular response to nanomaterial particulates.
Del Giudice G, Serra A, Saarimäki LA, Kotsis K, Rouse I, Colibaba SA, Jagiello K, Mikolajczyk A, Fratello M, Papadiamantis AG, Sanabria N, Annala ME, Morikka J, Kinaret PAS, Voyiatzis E, Melagraki G, Afantitis A, Tämm K, Puzyn T, Gulumian M, Lobaskin V, Lynch I, Federico A, Greco D. Del Giudice G, et al. Among authors: melagraki g. Nat Nanotechnol. 2023 Aug;18(8):957-966. doi: 10.1038/s41565-023-01393-4. Epub 2023 May 8. Nat Nanotechnol. 2023. PMID: 37157020 Free PMC article.
Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers.
Fotakis C, Megariotis G, Christodouleas D, Kritsi E, Zoumpoulakis P, Ntountaniotis D, Zervou M, Potamitis C, Hodzic A, Pabst G, Rappolt M, Mali G, Baldus J, Glaubitz C, Papadopoulos MG, Afantitis A, Melagraki G, Mavromoustakos T. Fotakis C, et al. Among authors: melagraki g. Biochim Biophys Acta. 2012 Dec;1818(12):3107-20. doi: 10.1016/j.bbamem.2012.08.009. Epub 2012 Aug 18. Biochim Biophys Acta. 2012. PMID: 22906712 Free article.
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.
Agelis G, Resvani A, Koukoulitsa C, Tůmová T, Slaninová J, Kalavrizioti D, Spyridaki K, Afantitis A, Melagraki G, Siafaka A, Gkini E, Megariotis G, Grdadolnik SG, Papadopoulos MG, Vlahakos D, Maragoudakis M, Liapakis G, Mavromoustakos T, Matsoukas J. Agelis G, et al. Among authors: melagraki g. Eur J Med Chem. 2013 Apr;62:352-70. doi: 10.1016/j.ejmech.2012.12.044. Epub 2013 Jan 2. Eur J Med Chem. 2013. PMID: 23376252 Free article.
Stability and binding effects of silver(I) complexes at lipoxygenase-1.
Vrontaki E, Leonis G, Avramopoulos A, Papadopoulos MG, Simčič M, Grdadolnik SG, Afantitis A, Melagraki G, Hadjikakou SK, Mavromoustakos T. Vrontaki E, et al. Among authors: melagraki g. J Enzyme Inhib Med Chem. 2015;30(4):539-49. doi: 10.3109/14756366.2014.951348. Epub 2014 Nov 6. J Enzyme Inhib Med Chem. 2015. PMID: 25373502
Rational drug design paradigms: the odyssey for designing better drugs.
Kellici T, Ntountaniotis D, Vrontaki E, Liapakis G, Moutevelis-Minakakis P, Kokotos G, Hadjikakou S, Tzakos AG, Afantitis A, Melagraki G, Bryant S, Langer T, Di Marzo V, Mavromoustakos T. Kellici T, et al. Among authors: melagraki g. Comb Chem High Throughput Screen. 2015;18(3):238-56. doi: 10.2174/1386207318666150305125638. Comb Chem High Throughput Screen. 2015. PMID: 25747445 Review.
88 results